IAMH
BEAM icon

IvyRock Asset Management (HK)’s Beam Therapeutics BEAM Stock Holding History

IvyRock Asset Management (HK)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Hold
8,600
– – 0.17% 19
2026
Q1 		$205K Hold
8,600
– – 0.12% 22
2025
Q4 		$238K Hold
8,600
– – 0.13% 19
2025
Q3 		$209K Buy
+8,600
New +$171K 0.09% 18

Other funds holding BEAM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
PIM
Peregrine Investment Management Toronto, Ontario, Canada $235M AUM 131.85% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

IvyRock Asset Management (HK)'s BEAM Position: Q2 2026 in Review

IvyRock Asset Management (HK) held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 8,600 shares worth $295K. The position accounts for 0.17% of the portfolio, ranked #19.

IvyRock Asset Management (HK) first reported a position in BEAM in Q3 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • IvyRock Asset Management (HK) held 8,600 shares of Beam Therapeutics worth $295K as of Q2 2026.
  • IvyRock Asset Management (HK) left its Beam Therapeutics share count unchanged in Q2 2026.
  • Beam Therapeutics made up 0.17% of IvyRock Asset Management (HK)'s portfolio in Q2 2026, its #19 holding.
  • IvyRock Asset Management (HK) first reported a position in Beam Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 65 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on IvyRock Asset Management (HK)'s 13F filing for Q2 2026, filed 4 Aug 2026.